| Different cognitive frailty models and health-and cognitive-related outcomes in older age: from epidemiology to prevention F Panza, M Lozupone, V Solfrizzi, R Sardone, V Dibello, L Di Lena, ... Journal of Alzheimer's disease 62 (3), 993-1012, 2018 | 334 | 2018 |
| Oral frailty and its determinants in older age: a systematic review V Dibello, R Zupo, R Sardone, M Lozupone, F Castellana, A Dibello, ... The Lancet Healthy Longevity 2 (8), e507-e520, 2021 | 206 | 2021 |
| Sensorial frailty: age-related hearing loss and the risk of cognitive impairment and dementia in later life F Panza, M Lozupone, R Sardone, P Battista, M Piccininni, V Dibello, ... Therapeutic Advances in Chronic Disease 10, 2040622318811000, 2019 | 116 | 2019 |
| BACE inhibitors in clinical development for the treatment of Alzheimer’s disease F Panza, M Lozupone, V Solfrizzi, R Sardone, C Piccininni, V Dibello, ... Expert review of neurotherapeutics 18 (11), 847-857, 2018 | 103 | 2018 |
| Oral frailty indicators to target major adverse health-related outcomes in older age: a systematic review V Dibello, F Lobbezoo, M Lozupone, R Sardone, A Ballini, G Berardino, ... Geroscience 45 (2), 663-706, 2023 | 76 | 2023 |
| Anti-amyloid-β protein agents for the treatment of Alzheimer’s disease: an update on emerging drugs M Lozupone, V Solfrizzi, F D’Urso, I Di Gioia, R Sardone, V Dibello, ... Expert Opinion on Emerging Drugs 25 (3), 319-335, 2020 | 74 | 2020 |
| Are antibodies directed against amyloid-β (Aβ) oligomers the last call for the Aβ hypothesis of Alzheimer's disease? F Panza, M Lozupone, V Dibello, A Greco, A Daniele, D Seripa, ... Immunotherapy 11 (1), 3-6, 2019 | 68 | 2019 |
| Oral frailty and neurodegeneration in Alzheimer’s disease V Dibello, M Lozupone, D Manfredini, A Dibello, R Zupo, R Sardone, ... Neural regeneration research 16 (11), 2149-2153, 2021 | 67 | 2021 |
| Nutritional intervention as a preventive approach for cognitive-related outcomes in cognitively healthy older adults: a systematic review V Solfrizzi, P Agosti, M Lozupone, C Custodero, A Schilardi, V Valiani, ... Journal of Alzheimer's Disease 64 (s1), S229-S254, 2018 | 60 | 2018 |
| Anti-plaque and antimicrobial efficiency of different oral rinses in a 3-day plaque accumulation model S Cantore, A Ballini, G Mori, V Dibello, M Marrelli, R Mirgaldi, D De Vito, ... J. Biol. Regul. Homeost. Agents 30 (4), 1173-1178, 2016 | 60 | 2016 |
| Full digital workflow for the treatment of an edentulous patient with guided surgery, immediate loading and 3D-printed hybrid prosthesis: The BARI technique 2.0. A case report P Venezia, F Torsello, V Santomauro, V Dibello, R Cavalcanti International journal of environmental research and public health 16 (24), 5160, 2019 | 58 | 2019 |
| Pharmacotherapy for the treatment of depression in patients with alzheimer’s disease: a treatment-resistant depressive disorder M Lozupone, M La Montagna, F D’Urso, C Piccininni, R Sardone, ... Expert opinion on pharmacotherapy 19 (8), 823-842, 2018 | 53 | 2018 |
| Characterization of human apical papilla-derived stem cells. S Cantore, A Ballini, D De Vito, FS Martelli, I Georgakopoulos, M Almasri, ... Journal of biological regulators and homeostatic agents 31 (4), 901-910, 2017 | 51 | 2017 |
| An old challenge with new promises: a systematic review on comprehensive geriatric assessment in long-term care facilities F Panza, V Solfrizzi, M Lozupone, MR Barulli, F D'Urso, R Stallone, ... Rejuvenation Research 21 (1), 3-14, 2018 | 47 | 2018 |
| Association between central and peripheral age-related hearing loss and different frailty phenotypes in an older population in Southern Italy R Sardone, F Castellana, I Bortone, L Lampignano, R Zupo, M Lozupone, ... JAMA Otolaryngology–Head & Neck Surgery 147 (6), 561-571, 2021 | 46 | 2021 |
| Nutritional interventions and cognitive-related outcomes in patients with late-life cognitive disorders: A systematic review V Solfrizzi, P Agosti, M Lozupone, C Custodero, A Schilardi, V Valiani, ... Neuroscience & Biobehavioral Reviews 95, 480-498, 2018 | 45 | 2018 |
| Associations between nutritional frailty and 8‐year all‐cause mortality in older adults: The Salus in Apulia Study R Zupo, F Castellana, V Guerra, R Donghia, I Bortone, C Griseta, ... Journal of Internal Medicine 290 (5), 1071-1082, 2021 | 44 | 2021 |
| The potential of solanezumab and gantenerumab to prevent Alzheimer’s disease in people with inherited mutations that cause its early onset F Panza, D Seripa, M Lozupone, V Solfrizzi, BP Imbimbo, MR Barulli, ... Expert opinion on biological therapy 18 (1), 25-35, 2018 | 40 | 2018 |
| Beverages consumption and oral health in the aging population: a systematic review R Zupo, F Castellana, S De Nucci, V Dibello, M Lozupone, G Giannelli, ... Frontiers in nutrition 8, 762383, 2021 | 34 | 2021 |
| Promising therapies for the treatment of frontotemporal dementia clinical phenotypes: from symptomatic to disease-modifying drugs G Logroscino, BP Imbimbo, M Lozupone, R Sardone, R Capozzo, ... Expert opinion on pharmacotherapy 20 (9), 1091-1107, 2019 | 31 | 2019 |
Francesco PanzaNeurodegenerative Disease Unit, Department of Basic Medicine, Neuroscience, and Sense OrgansAdresse e-mail validée de uniba.it